Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1612236-05-1

C14H19NO2 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1612236-05-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1612236-05-1 Structure

  • Basic information

    1. Product Name: C14H19NO2
    2. Synonyms: C14H19NO2
    3. CAS NO:1612236-05-1
    4. Molecular Formula:
    5. Molecular Weight: 233.31
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1612236-05-1.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C14H19NO2(CAS DataBase Reference)
    10. NIST Chemistry Reference: C14H19NO2(1612236-05-1)
    11. EPA Substance Registry System: C14H19NO2(1612236-05-1)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1612236-05-1(Hazardous Substances Data)

1612236-05-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1612236-05-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,1,2,2,3 and 6 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1612236-05:
(9*1)+(8*6)+(7*1)+(6*2)+(5*2)+(4*3)+(3*6)+(2*0)+(1*5)=121
121 % 10 = 1
So 1612236-05-1 is a valid CAS Registry Number.

1612236-05-1Upstream product

1612236-05-1Relevant articles and documents

SPIRO RING COMPOUND AS HEPATITIS C VIRUS (HCV) INHIBITOR AND USES THEREOF FIELD OF THE INVENTION

-

, (2014/06/23)

A compound of formula (I) or a stereoisomer, a geometric isomer. a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof is provided, which can be used for treating HCV infection or a HCV disorder. Also a pharmaceutical composition comprising the compound and the use of the compound and the pharmaceutical composition thereof are provided, which can also be used for treating HCV infection or a HCV disorder.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1612236-05-1